GlassScriptPhysician profile
Jill C Elmore
NPI 1285841270
$1,746.74
in general payments reported to CMS, 2019-2025
23 companies · $533 in 2025
The $533 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $239 · 2023: $274 · 2024: $254 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.46 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $600.15 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $248.75 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $148.53 | 2022-2025 | Trelegy Ellipta |
| Abbott Laboratories | $131.04 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Abbvie INC. | $122.37 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $109.31 | 2023-2025 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $56.20 | 2022-2023 | |
| Lundbeck LLC | $36.18 | 2024-2025 | Rexulti |
| Pfizer INC. | $35.06 | 2024 | |
| Axsome Therapeutics, INC. | $31.12 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $30.84 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $28.09 | 2025 | Lagevrio |
| Medtronic, INC. | $19.22 | 2024 | Venaseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Upsher-Smith Laboratories LLC | $18.75 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.00 | 2025 | Caplyta |
| Exact Sciences Corporation | $17.89 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $16.65 | 2021 | |
| Tactile Systems Technology INC | $15.04 | 2025 | Flexitouch Plus, Nimbl |
| Biohaven Pharmaceutical Holding Company LTD. | $12.85 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $11.53 | 2021 | |
| Amgen INC. | $11.26 | 2021 | |
| Genentech USA, INC. | $9.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Elmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.